Evanston-based Northfield Laboratories Inc. says it will receive $3.5 million from the federal military budget to continue trials of its synthetic blood substitute, PolyHeme, that could be used to treat criticially injured people, including soldiers. Details in a company press release and a Chicago Tribune story.

Leave a comment

The goal of our comment policy is to make the comments section a vibrant yet civil space. Treat each other with respect — even the people you disagree with. Whenever possible, provide links to credible documentary evidence to back up your factual claims.

Your email address will not be published.